Neurocrine Bioscience buy StockNews.com
Start price
22.07.23
/
50%
€89.78
Target price
22.07.24
-
Performance (%)
49.20%
End price
23.07.24
€133.95
Summary
This prediction ended on 23.07.24 with a price of €133.95. With a performance of 49.20% the BUY prediction by StockNews_com was a big success. StockNews_com has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Neurocrine Bioscience | 0.873% | 0.873% | -3.392% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
Comments by StockNews_com for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Neurocrine Bioscience
Stopped prediction by StockNews_com for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
23.09.23
23.09.23
-
23.09.24
23.09.24
-3.38%
24.09.24
24.09.24